Inhibitor development as switching full-lengthrecombinant FVIII to B-domain deleted recombinantFVIII in previously treated patients with hemophilia A:Taiwan’s experience
Chia-Yau Chang, S-H Chen, G-C Yeh, C-H Tsai , J-R Tsai, Y-L Liu
研究成果: 雜誌貢獻 › 特刊 › 同行評審